Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BMS-986207 |
Trade Name | |
Synonyms | BMS986207|BMS 986207 |
Drug Descriptions |
BMS-986207 is a human monoclonal antibody against T-cell immunoreceptor with Ig and ITIM domains (TIGIT), which removes the immune checkpoint blockade by preventing the interaction of TIGIT with its ligands, NECTIN2 (CD112) and PVR (CD155) (NCI Drug Dictionary). |
DrugClasses | Immune Checkpoint Inhibitor 149 TIGIT Antibody 19 |
CAS Registry Number | NA |
NCIT ID | C131907 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BMS-986207 | BMS-986207 | 0 | 2 |
BMS-986207 + COM701 + Nivolumab | BMS-986207 COM701 Nivolumab | 0 | 1 |
BMS-986207 + Dexamethasone + Pomalidomide | BMS-986207 Dexamethasone Pomalidomide | 0 | 1 |
BMS-986207 + Ipilimumab + Nivolumab | BMS-986207 Ipilimumab Nivolumab | 0 | 1 |
BMS-986207 + Nivolumab | BMS-986207 Nivolumab | 0 | 1 |